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a b s t r a c t
Epiboly, the ﬁrst morphogenetic cell movement that occurs in the zebraﬁsh embryo, is the process by
which the blastoderm thins and spreads to engulf the yolk cell. This process requires the concerted
actions of the deep cells, the enveloping layer (EVL) and the extra-embryonic yolk syncytial layer (YSL).
The EVL is mechanically coupled to the YSL which acts as an epiboly motor, generating the force
necessary to draw the blastoderm towards the vegetal pole though actomyosin ﬂow and contraction of
the actomyosin ring. However, it has been proposed that the endocytic removal of yolk cell membrane
just ahead of the advancing blastoderm may also play a role. To assess the contribution of yolk cell
endocytosis in driving epiboly movements, we used a combination of drug- and dominant-negative-
based approaches to inhibit Dynamin, a large GTPase with a well-characterized role in vesicle scission.
We show that Dynamin-dependent endocytosis in the yolk cell is dispensable for epiboly of the
blastoderm. However, global inhibition of Dynamin function revealed that Dynamin plays a fundamental
role within the blastoderm during epiboly, where it maintains epithelial integrity and the transmission of
tension across the EVL. The epithelial defects were associated with disrupted tight junctions and a
striking reduction of cortically localized phosphorylated ezrin/radixin/moesin (P-ERM), key regulators of
epithelial integrity in other systems. Furthermore, we show that Dynamin maintains EVL and promotes
epiboly progression by antagonizing Rho A activity.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Epiboly, generally deﬁned as the thinning and spreading of one
tissue over another, is a widely employed mechanism of morphogen-
esis that is essential for the development of most animals (Kane and
Adams, 2002). In ﬁsh, frogs and worms, epiboly is required for
blastopore closure and the successful completion of gastrulation
(Betchaku and Trinkaus, 1978; Keller, 1980;Warga and Kimmel, 1990;
Williams-Masson et al., 1997). In addition, in placental animals, it has
been proposed that spreading of the trophectoderm during implan-
tation is driven by an epiboly-like process (Kane and Adams, 2002).
Despite the fundamental nature of this mode of morphogenesis, the
cellular and molecular underpinnings of epiboly are poorly under-
stood (Lepage and Bruce, 2010).
Much of what we know regarding the mechanisms driving
epiboly, we have learned through the study of teleost develop-
ment. In teleost ﬁsh, such as Fundulus or zebraﬁsh, the blastoderm
begins its development on top of a large yolk cell. Epiboly involves
the coordinated vegetal movement of an epithelial sheet (envel-
oping layer, EVL), small groups/individual cells (deep cells, DEL)
and a syncytium (yolk syncytial layer, YSL) to completely engulf
the yolk cell and close the blastopore at the end of gastrulation
(Betchaku and Trinkaus, 1978; Trinkaus, 1951; Warga and Kimmel,
1990). The deep cells, which make up the embryo proper, are
covered by the single-cell thick EVL (Betchaku and Trinkaus, 1978;
Kimmel et al., 1990). The EVL margin is tightly attached to the
periphery of the YSL (external YSL, E-YSL), which lies at the
interface between the yolk mass and overlying deep cells
(Betchaku and Trinkaus, 1978; Kimmel and Law, 1985a). The
prevailing model is that the yolk functions as an epiboly motor,
driving the vegetal-ward movement of the YSL through the
concerted action of the yolk microtubule and actin cytoskeleton
(Behrndt et al., 2012; Betchaku and Trinkaus, 1978; Cheng
et al., 2004; Solnica-Krezel and Driever, 1994). By reason of its
tight association to the EVL, epiboly of the YSL draws the
blastoderm towards the vegetal pole (Betchaku and Trinkaus,
1978; Trinkaus, 1951).
It has been proposed that modiﬁcation of the yolk surface
also contributes to the motive forces that drive epiboly move-
ments (Betchaku and Trinkaus, 1978, 1986; Cheng et al., 2004;
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Solnica-Krezel and Driever, 1994). As the blastoderm advances
towards the vegetal pole during epiboly, the surface area of the
exposed yolk membrane is progressively reduced (Cheng et al.,
2004). In both Fundulus and zebraﬁsh, the yolk membrane is likely
recovered by a discrete region of active endocytosis, located just
ahead of the advancing blastoderm margin. This phenomenon is
readily observed through the rapid uptake of ﬂuorescent ﬂuid-
phase markers into vesicles (Betchaku and Trinkaus, 1986; Solnica-
Krezel and Driever, 1994). Vesicles labelled in this manner form
a thick, circumferential band within the E-YSL, a region where
the yolk cell is actin-rich and its membrane is highly rufﬂed
(Betchaku and Trinkaus, 1986; Cheng et al., 2004). In Fundulus, this
pattern of ﬂuid-phase endocytosis is initiated upon the onset of
epiboly and is maintained for the duration of epiboly progression
(Betchaku and Trinkaus, 1986). In contrast, in the zebraﬁsh,
marginal yolk cell endocytosis has been reported to be restricted
to the later, progression phase of epiboly when the bulk of yolk cell
membrane is removed (Cheng et al., 2004; Solnica-Krezel and
Driever, 1994).
Although it is generally held that bulk endocytic removal of the
yolk cell membrane is required for the normal progression of
epiboly in the zebraﬁsh, the functional consequence of inhibiting
this process has never been examined. To determine the relative
contribution of yolk membrane endocytosis on YSL epiboly, we
focused our attention on the large multi-domain GTPase, Dyna-
min, a component of the endocytic machinery that is common to
many mechanisms of endocytosis (Doherty and McMahon, 2009;
Ferguson and De Camilli, 2012).
In mammals, there are three dynamin genes (dnm1–3), with
dnm1 expressed in neurons, dnm3 expressed primarily in the
brain, lung and testis and dnm2 expressed ubiquitously (Cook
et al., 1994; Nakata et al., 1991, 1993; Sontag et al., 1994).
Drosophila possess a single dynamin homolog, shibire, which is
expressed ubiquitously during early development (Chen et al.,
1991, 1992; van der Bliek and Meyerowitz, 1991). Dynamin is best
known for its role in coated pit formation and vesicle ﬁssion
during clathrin-mediated endocytosis (CME) (Damke et al., 2001;
Hill et al., 2001; Kosaka and Ikeda, 1983a; Loerke et al., 2009; van
der Bliek and Meyerowitz, 1991). The bulk uptake of plasma
membrane and extracellular ﬂuid, however, is predominantly
through Clathrin-independent endocytic (CIE) mechanisms, which
account for an estimated 40–70% of constitutive ﬂuid-phase
internalization depending on the cell type (Cheng et al., 2006;
Howes et al., 2010; Sabharanjak et al., 2002; Sandvig et al., 1987).
Whether Dynamin regulates CIE mechanisms and, in particular
those that involve the uptake of ﬂuid-phase, is a debated issue as
different means of Dynamin inhibition have varying effects
depending on the experimental context (Altschuler et al., 1998;
Cao et al., 2007; Damke et al., 1994, 1995; Guha et al., 2003;
Herskovits et al., 1993; Kosaka and Ikeda, 1983b; Lundmark et al.,
2008; Macia et al., 2006; Sabharanjak et al., 2002).
Using a combination of drug- and dominant-negative based
approaches to inhibit the function of Dynamin in the developing
zebraﬁsh embryo, we show that epiboly-afﬁliated marginal ﬂuid-
phase endocytosis is a partially Dynamin-dependent process.
However, yolk-biased knockdown of Dynamin had little effect on
epiboly progression, suggesting Dynamin-dependent endocytic
recovery of yolk membrane is dispensable for the successful
completion of epiboly. Global means of Dynamin inhibition, on
the other hand, did affect epiboly of the blastoderm, suggesting
Dynamin regulates epiboly in another manner. We ﬁnd the epiboly
delay induced by Dynamin inhibition is associated with profound
morphological and structural defects in the EVL. We present
evidence suggesting that Dynamin maintains EVL integrity
through the regulation of the ezrin/radixin/moesin (ERM) family
of proteins and the small GTPase Rho A.
Results
Dynamin is required for successful completion of epiboly, but
Dynamin-dependent ﬂuid-phase endocytosis in the yolk cell is
dispensable
We inhibited Dynamin, a large GTPase with a well-
characterized role in vesicle scission, to test whether its function
was required for epiboly initiation and progression. Dynasore is a
rapid-acting, cell-permeable, reversible inhibitor of Dynamin
GTPase activity which reduces endocytosis by inhibiting vesicle
ﬁssion (Macia et al., 2006). Dechorionated embryos were bathed in
embryo medium (EM) containing 0.1% DMSO or 75 μM dynasore
(dyna) for the duration of epiboly. A strong and consistent delay in
epiboly progression was observed in 97% (n¼325) of embryos
receiving sustained dynasore treatment from oblong-sphere stage
(3.7–4 h post fertilization, hpf) and continuing through the dura-
tion of doming and progression (Fig. 1A–C). The effect on epiboly
initiation was subtle and highly variable. Dynasore treated
embryos appeared to dome in a timely fashion; however, the
blastoderm often did not dome in a uniform manner (Fig. 1C,
arrowhead). Epiboly delay was ﬁrst evident early in the progres-
sion phase, with dynasore treated embryos reaching only 30–40%
epiboly when controls had reached the 50% mark (Fig. 1A′–C′).
Epiboly of the deep cells and EVL was consistently delayed in
response to Dynamin inhibition, whereas the progression of the
YSL was partially affected (Fig. 1D–G). While the main YSN front
was located near the delayed blastoderm margin in dynasore
treated embryos, 80% (n¼10) of embryos had small clusters of
YSN that had escaped the YSN front and had undergone epiboly to
approximately the same extent as controls (Fig. 1F, arrowheads).
As indicted by the presence of the embryonic shield, dynasore
treated embryos began to gastrulate at the same time as controls,
thus the delay was not likely caused by a general developmental
delay (Fig. 1A′–C′, arrowheads). Prolonged treatment (beyond 60%
epiboly) resulted in a high rate of mortality, with the majority of
embryos lysing their yolk.
To conﬁrm that the epiboly delay in dynasore treated embryos
was speciﬁc to inhibiting Dynamin function, we expressed a
dominant-negative mutant version of Dynamin 2 (K44A, DN-
Dnm2) which carries a point mutation in its nucleotide binding
site, reducing its ability to bind GTP (Damke et al., 1994). Expres-
sion of this construct has been shown to disrupt endogenous
Dynamin function and inhibit vesicle scission in other systems. A
similar, but less robust, effect was attained when RNA encoding
DN-Dnm2 was injected into the yolk at the 1-cell stage. Approxi-
mately 66% of embryos globally expressing DN-Dnm2 experienced
a delay in epiboly starting in the early progression phase (n¼169,
Fig. 2A–C, E), but embryos managed to successfully complete
epiboly. As observed in dynasore treated embryos, epiboly of the
deep cells, EVL and YSL was delayed in response to global DN-
Dnm2 expression (n¼10, Fig. 2F, Supplementary Fig. S1).
Next, we tested whether inhibition of Dynamin impeded ﬂuid-
phase endocytosis in the yolk cell by examining the uptake of a
ﬂuorescent ﬂuid-phase marker, FITC, in embryos with compro-
mised Dynamin function. Relative to DMSO control treated
embryos, 100% (n¼20) of dynasore treated embryos had fewer
FITC-containing vesicles at the margin (Fig. 3A and B). In these
embryos, the number of FITC-containing vesicles was reduced by
an estimated 62% (Fig. 3E). Unexpectedly, we observed that ﬂuid-
phase markers penetrated the EVL and seeped into the deep cell
layer of dynasore treated embryos (86%, n¼29, Fig. 3B, arrow),
suggesting that the barrier function of the EVL epithelium was
compromised in response to dynasore treatment. Similarly, 89% of
embryos globally expressing DN-Dnm2 showed reduced uptake of
our ﬂuid-phase marker (n¼9, Fig. 3C and D). On average, global
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expression of DN-Dnm2 caused 52% reduction in FITC containing
vesicles at the margin (Fig. 3F). Thus, while DN-Dnm2 had a more
mild effect on epiboly than dynasore treatment, both means of
Dynamin inhibition affected ﬂuid-phase endocytosis at the margin
to a similar extent. In addition, we saw that inhibition of Dynamin
caused defects in not only the yolk cell, but also the EVL.
These data led us to question whether the epiboly delay caused
by Dynamin inhibition was the result of disrupting Dynamin-
dependent ﬂuid-phase endocytosis in the yolk cell or due to defects
in the blastoderm. To differentiate between these two possibilities,
we biased expression of DN-Dnm2 to the yolk cell and examined its
effect on epiboly. To achieve a regionalized knockdown of Dynamin
function in the yolk cell, RNA encoding DN-Dnm2 was injected into
the yolk at the 16–32 cell stage (1.5–1.75 hpf), after cytoplasmic
streaming towards the blastoderm has slowed (Fig. 2E,
Supplementary Fig. S1). Yolk-biased expression of DN-Dnm2 failed
to cause a signiﬁcant epiboly delay phenotype (13% delayed, n¼179,
Fig. 2D, Supplementary Fig. S1). Yolk-biased expression of DN-Dnm2
did not signiﬁcantly disrupt epiboly of the EVL, deep cells or the YSL
(Fig. 2G). To conﬁrm that our strategy of yolk-biased expression of
DN-Dnm2 was effectively inhibiting ﬂuid-phase endocytosis, we
examined uptake of our ﬂuid-phase marker FITC under these
conditions. Indeed, the number of FITC containing vesicles was
reduced in 88% of the embryos examined (n¼24, Supplementary
Fig. S1), with an average reduction of 48% (Fig. 3F). Therefore, while
yolk-biased expression of DN-Dnm2 can effectively reduce ﬂuid-
phase endocytosis in the yolk cell to levels comparable to that of
global Dynamin inhibition, embryos can undergo normal epiboly.
These data suggest that Dynamin-dependent endocytic removal of
yolk cell membrane is not required for the proper progression of
epiboly. Consistent with these data, we found that the marginal
pattern of ﬂuid-phase endocytosis emerges prior to the onset of
epiboly and is not restricted to the yolk cell (Supplementary Fig. S2),
implying that this phenomenon might serve some purpose other
than to drive epiboly movements.
Dynamin is required to support EVL cell morphology and epithelial
integrity
Because yolk-biased Dynamin inhibition failed to have any effect
on epiboly, we attributed the epiboly delay observed upon global
inhibition of Dynamin to defects in the blastoderm. We noted that
the barrier function of the EVL was compromised in dynasore treated
embryos, as evidenced by the passage of our ﬂuid-phase marker into
the deep cell layer. This observation, coupled with recent work
highlighting the importance of proper EVL speciﬁcation and integrity
for epiboly (Carreira-Barbosa et al., 2009; Fukazawa et al., 2010; Pei
et al., 2007; Sabel et al., 2009; Siddiqui et al., 2010), prompted us to
examine Dynamin's function in the EVL in more detail.
To further characterize this EVL defect, embryos were bathed in
EM, DMSO or dynasore, ﬁxed at 60% epiboly and stained for
F-actin. Striking defects in EVL cell morphology were revealed by
phalloidin staining (Fig. 4A–C). Most notably, EVL cells became
irregular in shape and size in response to dynasore treatment,
with rounded cells scattered across the EVL (98%, n¼45, Fig. 4C
and C′). In some cases, the rounded cells were observed with
actin-based processes below the plane of the EVL, extending into
the underlying deep cells (Fig. 4C′, arrowheads). Actin organiza-
tion in the marginal EVL cells and in the E-YSL has been shown to
be important for late epiboly progression and blastopore closure
(Köppen et al., 2006). However, the marginal actin band at the
leading edge of the EVL and the punctate E-YSL actin band were
intact in dynasore treated embryos (Fig. 4C, arrowhead), suggest-
ing Dynamin does not play a signiﬁcant role in organizing actin in
this region.
Fig. 1. Dynasore treatment impairs epiboly of the deep cells and EVL. ((A)(C)) Live images of a representative untreated ((A)(A″)), DMSO control treated ((B)(B″)) and
dynasore treated embryo ((C)(C″)) at epiboly initiation ((A)(C)), mid-epiboly ((A′)(C′)) and late epiboly progression ((A″)(C″)). Arrowhead in (C) indicates uneven
doming of the blastoderm, arrowheads in ((A′)(C′)) indicate the embryonic shield and arrows in ((A″)(C″)) mark the approximate position of the advancing blastoderm
margin. ((D)(F)) Phalloidin (red) and sytox (green) co-staining showing the effect of dynasore treatment (F) on epiboly of the deep cell margin (DCM), EVL and YSL (marked
by the YSN). Arrowheads in (F) show the advanced position of YSN ahead of the blastoderm margin. (G) Quantiﬁcation of the effect of dynasore treatment on epiboly
progression. Bars represent the mean percentage of yolk coverage (n¼10). Error bars indicate standard deviation and statistical signiﬁcance was determined by t-test,
nPo0.01. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Live time-lapse confocal imaging of dynasore treated embryos
expressing membrane-bound GFP (mGFP) revealed that EVL cells lost
contact with their neighbours (Fig. 4D, arrows) and were sometimes
extruded basally from the epithelium (Fig. 4D and K, arrowheads).
While still maintaining contact basally, apical gaps periodically formed
between adjacent membranes, giving the EVL a cobblestone-like
appearance (Fig. 4D and K). Having lost partial contact with neigh-
bouring cells, EVL cells tended to round at their apices and lose their
characteristic polygonal shape. Live imaging also revealed that the
structural defects in the EVL were transient. EVL cells that had lost
contact were occasionally observed re-establishing contact with their
neighbours (Fig. 4D, arrows) or gaps were mended with cells from
below the plane of the EVL (Fig. 4D, arrowheads).
As tight junctions are required for the maintenance of barrier
function in epithelia (Gumbiner, 1993), we examined whether the
tight junction component ZO-1 was disrupted or mislocalized in
dynasore treated embryos. ZO-1 antibody staining was irregular
and unevenly distributed around the periphery of EVL cells in the
majority of embryos examined (91%, n¼35, Fig. 4EG, arrows).
While some cells appeared to have the normal distribution of ZO-
Fig. 2. Dynamin-dependent ﬂuid-phase endocytosis within the yolk cell is dispensable for epiboly progression. ((A)(D)) Live images of epiboly in a representative
uninjected embryo ((A)(A″)), control injected embryo ((B)(B″)) and embryos expressing DN-Dnm2 globally ((C)(C″)) or in a yolk-biased manner ((D)(D″)). Embryos
are shown in lateral view at approximately 30% epiboly ((A)(D)), 60% epiboly ((A′)(D′)) and at bud stage ((A″)(D″)). Arrows in ((A′)(D′)) indicate the position of the
advancing blastoderm margin. (E) Schematic diagram of global versus yolk-biased injection method. ((F) and (G)) Quantiﬁcation of the effect of global and yolk-biased DN-
Dnm2 expression on epiboly progression. Bars represent the mean percentage of yolk coverage. Error bars indicate standard deviation and statistical signiﬁcance was
determined by t-test, nPo0.01.
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1, staining was hardly visible in adjacent cells. In 57% (n¼35) of
the embryos examined, separations between adjacent EVL mem-
branes were observed (Fig. 4G, arrowheads). The EVL is attached to
the YSL membrane by tight junctions, which prevents deep cells
from surpassing the EVL margin during epiboly (Köppen et al.,
2006). Consistent with the discontinuous ZO-1 staining observed
in the EVL, cells occasionally superseded the EVL margin, as
observed in live dynasore treated embryos expressing mRFP
(Fig. 3B, arrowheads). These could be deep cells that have
surpassed the EVL margin, suggesting the tight junction EVL-YSL
attachment was disrupted. Alternatively, they may be EVL cells
that have detached from the epithelium.
ERM (ezrin/radixin/moesin) proteins play a structural role in
epithelia, providing a physical link between the plasma membrane
and cortical cytoskeleton (Bretscher, 1999; Sato et al., 1992). It has been
shown in other systems that the ERM family of proteins is important
for cortical actin assembly and the maintenance of epithelial integrity.
In Drosophila moesin mutants, the epithelial cells which make up the
wing imaginal discs have disorganized cortical actin and are basally
extruded from the epithelium (Speck et al., 2003). These defects were
reminiscent of those observed in the EVL of dynasore treated embryos,
therefore, we examined them for changes in activated ERM. Phos-
phorylated ERM (P-ERM) was detected at the periphery of EVL cells,
co-localizing with the cortical actin belt, in untreated and DMSO
treated controls (Fig. 4H and I). In contrast, membrane localization of
P-ERM was severely disrupted in 90% of embryos treated with
dynasore (n¼21, Fig. 4J). Little to no P-ERM co-localized with the
cortical actin belt in dynasore treated embryos and 95% (n¼21) of
embryos examined had scattered EVL cells with an apical membrane
enrichment of P-ERM (Fig. 4J′, arrowheads).
Fig. 3. Dynamin-dependence of ﬂuid-phase endocytosis at the blastoderm margin. ((A)(D)) The effect of dynasore treatment ((A) and (B)) and global DN-Dnm2 ((C) and
(D)) expression on the uptake of a ﬂuorescent ﬂuid-phase marker, FITC. All embryos are globally expressing mRFP to show the position of the EVL margin. Arrow in (B) shows
the passage of our ﬂuid-phase marker into the deep cell layer, while arrowheads indicate cells which have passed the EVL margin. ((E) and (F)) Quantiﬁcation of vesicle
number in embryos treated with dynasore and those expressing DN-Dnm2. Bars represent the least squares mean vesicle number7standard error. Statistical signiﬁcance
was tested using two-way ANOVAs. Dynasore treatment: F3,60¼43.90, Po0.0001; Day: F5,60¼18.01, Po0.0001. A Tukey HSD test indicated the control differed signiﬁcantly
from dynasore treatment in both control injected and dn-rho RNA injected groups. Global DN-Dnm2: F1,14¼16.63, P¼0.0011; Day: F2,14¼5.57, P¼0.0166. Yolk-biased DN-
Dnm2: F1,36¼27.70, Po0.0001; Day: F4,36¼3.05, P¼0.029.
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Fig. 4. Dynamin is essential for maintaining EVL cell morphology and epithelial integrity. ((A)(C)) Phalloidin staining showing EVL cell morphology and F-Actin
organization in untreated ((A) and (A′)), DMSO control treated ((B) and (B′)) and dynasore treated embryos ((C) and (C′)). Low magniﬁcation images in ((A)(C)) show actin
organization in the EVL and yolk cell. Arrowhead in (C) shows that the actomyosin ring in the E-YSL is intact. Higher magniﬁcation projections in ((A′)(C′)) are taken from
the animal pole. Representative XZ planes from the Z-stacks in ((A′)(C′)) are shown below each image. Arrowheads in (C′) indicate EVL cells that are protruding below the
plane of the EVL. (D) Time-lapse imaging of an embryo expressing mGFP and treated with dynasore. Single planes taken from the sub-apical region of the EVL are shown. The
red dot marks a cell tracked over a 32 min period. Arrows mark a transient gap formed between the membranes of adjacent cells and arrowheads show a cell from below the
plane of the EVL which is incorporated into the EVL and subsequently basally extruded. These defects were never observed in control time-lapse images. ((E)(G))
Localization of ZO-1 in the EVL of untreated (E), DMSO control treated (F) and dynasore treated (G) embryos. ((H)(J)) Localization of P-ERM in the EVL of untreated ((H) and
(H′)), DMSO control treated ((I) and (I′)) and dynasore treated ((J) and (J′)) embryos. Overlay with phalloidin staining is shown in ((H′)(I)). (K) An XZ plane taken from a
time-lapse as in (D) showing an EVL cell (red dot) sending a protrusion into the underlying deep cells (arrowhead). Apical to the top. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Similar morphological defects were observed when we mosai-
cally expressed DN-Dnm2 within the EVL. We injected plasmids
encoding UAS-gfp-CAAX or UAS-zdnm2-like-k44a-gfp-CAAX, into
transgenic embryos which conditionally express the optimized
Gal4 KalTA4 under the control of a keratin 18 (krt18) promoter,
driving EVL expression of gfp alone or the separate expression of
gfp and dn-dnm2l from a bidirectional promoter. Because the EVL
contributes cells to the deep cell layer up until late blastula stages
(Kimmel and Law, 1985b), we induced the expression of KalTA4
with tamoxifen at 30% epiboly to generate small clones of mostly
EVL cells that express GFP or GFP and DN-Dnm2. Note that while
induction with tamoxifen at 30% epiboly minimizes the number of
GFP-labelled deep cells, some deep cell labelling is still observed
(Fig. 5A′ and B′, arrowheads). Embryos were ﬁxed at 60–90%
epiboly (7–9 hpf), stained with rhodamine phalloidin and exam-
ined for defects in EVL cell morphology (Fig. 5A and B). The effects
of EVL-biased DN-Dnm2 expression were mild in comparison to
those caused by dynasore treatment; however, distorted EVL cell
morphology was evident in phalloidin stained embryos (100%,
n¼24 embryos, Fig. 5B). The apical surface area of EVL cells
expressing DN-Dnm2 was, on average, smaller than that of cells
which expressed GFP alone (Fig. 5C). EVL cells in control injected
embryos made contact with an average of 6.0 neighbouring cells,
along their edges (n¼130 cells, Fig. 5D). The irregular cell
Fig. 5. EVL-biased DN-Dnm2 expression disrupts cell morphology, cell packing and ZO-1 localization. ((A) and (B)) EVL cell morphology in embryos mosaically expressing
GFP alone (cntl inj, (A)(A″)) or GFP and DN-Dnm2l ((B)(B″)). Phalloidin staining is shown in ((A) and (B)), GFP-marked clones in ((A′) and (B′)) and overlay in ((A″)
and (B″)). Arrowheads in ((A′) and (B′)) show deep cells that have been labeled. Arrow in (B″) indicates a DN-Dnm2l expressing cell which is abnormally small, lacks its
characteristic polygonal shape and contacts a neighbouring cell at a vertex instead of along its edge. ((C) and (D)) Quantiﬁcation of the effect of DN-Dnm2l on EVL cell apical
surface area and cell packing. ((E) and (F)) ZO-1 localization in GFP ((E) and (E′)) and DN-Dnm2l ((F) and (F′)) expressing clones. Arrowheads in (E) indicate regions of
reduced and discontinuous ZO-1 antibody staining.
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morphology of DN-Dnm2 expressing cells, however, increased this
average to 6.3 contacts per cell, with cells meeting not only along
their edges, but also at their vertices (n¼211 cells, Fig. 5B″, arrow,
C). The irregularity in cell size and non-optimal cell packing gave
the EVL a disorganized appearance. In addition, ZO-1 antibody
staining was reduced or discontinuous in 68% of cells expressing
DN-Dmn2 (n¼41 cells, Fig. 5E and F). Despite the defects in EVL
cell morphology and ZO-1 distribution, epiboly proceeded in a
timely manner. The comparatively mild phenotype is likely due to
the limited size and distribution of DN-Dnm2 expressing clones
and/or the shortened timeframe in which Dynamin function was
disrupted.
Dynamin is required for the proper localization of adherens junction
components
From our live imaging of dynasore treated embryos, we noted
that adjacent EVL cells transiently lost contact apically, while
maintaining contact basally. As adherens junctions (AJ) mediate
the intercellular adhesion within an epithelium and are localized
sub-apically, we suspected that the AJ were disrupted in the EVL of
dynasore treated embryos. We bathed embryos expressing
membrane-bound GFP (mGFP) in EM, DMSO or dynasore and
stained for F-actin, β-Catenin and pan-Cadherin. Stained embryos
were subsequently imaged from the animal pole by confocal
microscopy (Figs. 4A′C′, 6). F-actin and the components of the
AJ junction complex are normally localized to the periphery of
each cell in the EVL in untreated and control treated embryos
(Figs. 4A′ and B′, 6A, B, D and E). We anticipated that staining for AJ
components would be reduced or absent at the intercellular
junctions, similar to what we observed with ZO-1 staining. While
we did observe some regions of the EVL devoid of junctional
staining (Fig. 6F), we regularly detected enhanced staining for
F-actin, β-Catenin and Cadherin at the periphery of EVL cells in
dynasore treated embryos (Figs. 4C′, 6C and F).
We rotated our Z-stack images to visualize the localization of
these markers with respect to the apical-basal axis (Fig. 4A′C′
below XY projections, 6A′F′). Phalloidin stains the F-actin-rich
microvilli which cover the apical surface of the EVL as well as the
cortical actin belt (Fig. 4A′ and B′). While phalloidin staining was
observed in its normal location on the apical surface and at the
periphery of EVL cells in dynasore treated embryos, ectopic F-actin
was also detected in the basal-most region of rounded EVL cells
(Fig. 4C′). β-Catenin, which is normally localized to basal-lateral
membrane and intercellular junction of EVL cells (Fig. 6A′ and B′),
was expanded basally, along the entire length of the lateral
membrane in response to Dynamin inhibition (100%, n¼23,
Fig. 6C′, arrowhead). Cadherins normally co-localize with β-
Catenin at EVL cell junctions and the basal lateral membrane
(Fig. 6D′ and E′). Junctional pan-Cadherin antibody staining was
expanded in a manner comparable to β-Catenin staining (82%,
n¼11 embryos, Fig. 6F′, arrowhead). Together these data show
that the proper positioning of the cortical actin belt, β-Catenin and
Cadherin along the apical and basal axis depends on Dynamin
function.
Concomitant with a basal-ward shift in the position of AJ
markers, we observed an expansion of apical membrane. aPKC,
which marks the apical surface of the EVL in untreated and control
treated embryos, was found to be expanded basally in response to
dynasore treatment (100%, n¼11, Fig. 6G′ I′, arrowhead). In EVL
cells rounded by dynasore treatment, aPKC staining was observed
on the lateral membrane between adjacent cells. aPKC staining
also revealed that the apical membrane is highly folded in
embryos treated with dynasore, particularly the apical membranes
Fig. 6. Dynamin inhibition disrupts the organization of the adherens junction. ((A)(I)) Localization of adherens junction components β-Catenin ((A)(C)) and E-Cadheren
((D)(F)), and apical membrane marker aPKC ((G)(I)) in untreated ((A), (D) and (G)), DMSO control treated ((B), (E) and (H)) and dynasore treated ((C), (F) and (I)) embryos.
Confocal projections from the animal pole are shown in ((A)(I)). Arrowheads in ((C), (F) and (I)) indicate cells with enriched staining at the junction between cells. Arrows
in (I) indicate folds in the apical membrane. Enlarged representative XZ planes showing the localization of each protein with respect to the apicalbasal axis of the EVL are
shown in ((A′)(I′)). Membranes are marked with mGFP for reference and apical is to the top. White dots are placed approximately above the intercellular junctions.
Arrowheads indicate regions of aberrant antibody staining.
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of the most distorted cells (100%, n¼11, Fig. 6I, arrows). This
correlates with a potential reduction in tension across the EVL,
which is likely the result of integrity issues discussed above.
Dynasore-induced EVL defects are not a result of failed differentiation
or apoptosis
Zebraﬁsh poky/chuk/ikk1 mutants fail to differentiate the EVL,
do not maintain a permeability barrier and also have delayed
epiboly (Fukazawa et al., 2010). To determine whether the EVL
properly differentiates in dynasore treated embryos, we treated
embryos from oblong-sphere stage until 75% epiboly and per-
formed whole-mount in situ hybridization for the epithelial
differentiation marker, keratin 4 (krt4, Fig. 7A–C). krt4 expression
was only mildly affected by Dynamin inhibition, with 64% of
embryos displaying small patches with reduced staining (n¼92,
Fig. 7C, arrowheads). Under our standard treatment paradigm, we
placed embryos in dynasore prior to sphere stage when the EVL
becomes lineage restricted and fully differentiated (Kimmel and
Law, 1985b). Next, we asked whether EVL cells fail to differentiate
in the presence of dynasore or whether EVL cells failed to maintain
their EVL fate. We treated embryos with dynasore at 40% epiboly,
after the EVL is differentiated, ﬁxed them at 90% epiboly and
stained them for krt4. Similar to embryos treated under our
standard paradigm, krt4 expressionwas mildly reduced in a patchy
manner in embryos treated with dynasore at 40% epiboly (100%,
n¼20, data not shown). Embryos treated with dynasore at 40%
epiboly showed the same defects in EVL cell morphology as those
observed with earlier treatment and also delayed epiboly (data not
shown). Taken together, these results suggest that the EVL defects
observed upon dynasore treatment are not caused by a wide-
spread failure to differentiate the EVL. Instead, some EVL cells fail
to maintain their epithelial identity in the presence of Dynamin
inhibition, which may be a secondary effect of losing epithelial
integrity.
Loss of epithelial identity, disrupted polarity and cell extrusion
can occur when epithelial cells undergo cell death (Eisenhoffer
and Rosenblatt, 2011; Wang et al., 2011). To determine whether
krt4-positive EVL cells were eliminated from the epithelium due to
apoptosis, dynasore treated embryos were stained with both
phalloidin and anti-cleaved Caspase 3 (Fig. 7D–F). Apoptotic cell
death was not widespread in dynasore treated embryos. Few
Caspase 3-positive cells were found in dynasore treated embryos
(1–5 cells in 88%, n¼8, Fig. 7F) and none of these cells were
incorporated in the EVL (n¼17 cells, Fig. 7F inset), suggesting they
become apoptotic after they have been extruded from the epithe-
lium. Constricting cells had intact nuclei (Fig. 8K, arrowhead),
further suggesting that constricted cells were not undergoing cell
death prior to extrusion. This is reminiscent of a stochastic, live
cell extrusion mechanism used to maintain optimal cell packing in
the Drosophila notum epithelium (Marinari et al., 2012).
Dynamin maintains EVL integrity through the regulation of Rho A
activity
The most striking defect observed in dynasore treated embryos
was a loss of EVL integrity, accompanied by a reduction of cortical
activated ERM. Although we were able to phenocopy the EVL and
epiboly defects associated with Dynamin inhibition by injecting a
previously published morpholino (MO) directed against ezrin2
(Link et al., 2006; Schepis et al., 2012), we were not able to rescue
the effects of dynasore treatment by ezrin2 over-expression
(Supplementary Fig. S3). We attribute this to an over-expression
phenotype in ezrin2 injected embryos that closely resembled that
of dynasore treatment.
Antagonizing Rho function can rescue the integrity of the wing
imaginal disc epithelium in Drosophila moesin mutants (Speck
et al., 2003). In addition, defects in cell morphology in the
intestinal epithelium of mouse ezrin mutants were associated
with increased Rho activity (Casaletto et al., 2011). Thus, to
circumvent the issues associated with ezrin2 over-expression, we
shifted our focus to the small GTPase Rho A. We attempted to
rescue the dynasore phenotype by antagonizing Rho A function.
Embryos were injected at the 1-cell stage with RNA encoding H2A
Fig. 7. Dynasore treatment does not cause major defects in EVL speciﬁcation or apoptosis. ((A)(C)) Expression of keratin 4 (krt4), a marker of EVL differentiation, in
untreated (A), DMSO control treated (B) and dynasore treated (C) embryos. Arrowheads in (C) indicate regions with reduced krt4 staining. ((D)(F)) Co-staining of untreated
(D), DMSO treated (E) and dynasore treated (F) embryos with phalloidin and anti-cleaved Caspase 3, a marker of apoptotic cell death. Few Caspase 3-positive cells are
observed in (F). Inset in (F) shows that these cells are not incorporated in the EVL.
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mCherry alone (cntl inj, nuclear localized) or H2A mCherry and
DN-Rho A (dn-rho) and then treated with EM, DMSO or dynasore
(Fig. 8). Control injected embryos treated with dynasore showed
the typical epiboly delay (Fig. 8C and M) and EVL defects (Fig. 8G
and K) characteristic of dynasore treatment. Embryos that were
co-injected with RNA encoding DN-Rho, on the other hand,
showed a signiﬁcant improvement in both epiboly progression
(Fig. 8D and M) and EVL cell morphology (83%, n¼18, Fig. 8H
and L).
Rho has been implicated as a negative regulator of endocytosis
in other contexts (Lamaze et al., 1996). To determine whether DN-
Rho restored epiboly in dynasore treated embryos by restoring
endocytosis at the margin, we examined the uptake of ﬂuid-phase
in DMSO and dynasore treated embryos expressing DN-Rho
(Fig. 3E). DN-Rho did not signiﬁcantly affect ﬂuid-phase endocy-
tosis under control treatment conditions (n¼17, Fig. 3E). Embryos
expressing DN-Rho and treated with dynasore have a 50% reduc-
tion in vesicles relative to control injected DMSO controls (n¼16).
This reduction in endocytosis was not statistically signiﬁcant from
the 62% reduction observed in control injected embryos treated
with dynasore (n¼20), suggesting that DN-Rho is not mediating
its rescue effect by restoring marginal ﬂuid-phase endocytosis.
These data also provide additional evidence that endocytic
removal of the yolk membrane is dispensable for epiboly
Fig. 8. Dynamin maintains EVL integrity and epiboly through the regulation of Rho A. ((A)(D)) Live images of epiboly in control injected embryos ((A)(C)) and embryos
expressing DN-Rho (D) when left untreated (A), treated with DMSO (B) or treated with dynasore ((C) and (D)). ((E)(L)) Phalloidin staining of embryos injected and treated
as in ((A)(D)). High magniﬁcation images in ((I)(L)) are taken from the animal pole and nuclei are marked by H2A mCherry. Arrowhead in (K) indicates a constricted cell
that has an intact nucleus. (M) Quantiﬁcation of the rescue of dynasore-induced epiboly delay by expression of DN-Rho. Bars represent the percentage of embryos displaying
an epiboly delay7standard deviation. Statistical signiﬁcance was determined by t-test, Po0.0001.
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progression, as dynasore treated embryos rescued by expression of
DN-Rho undergo epiboly normally despite having reduced mar-
ginal endocytosis.
Discussion
Dynamin is a key regulator of marginal ﬂuid-phase endocytosis
Since the ﬁrst description of ﬂuid-phase endocytosis at the margin
in the related teleost ﬁsh Fundulus, we have learned little about the
molecular underpinnings controlling this process. From the original
studies in Fundulus and more recent work in zebraﬁsh, we know that
marginal endocytosis occurs in the E-YSL, a region where the yolk cell
membrane is highly rufﬂed (Betchaku and Trinkaus, 1986; Cheng et al.,
2004). In Fundulus, uncoated rod-shaped vesicles are predicted to form
from the fusion of adjacent membrane rufﬂes in the E-YSL (Betchaku
and Trinkaus, 1986). In the zebraﬁsh, the region of marginal endocy-
tosis overlaps with the punctate actin band in the E-YSL (Cheng et al.,
2004), but whether the punctate actin band may be involved in
regulating this process has not been tested. Here we identify Dynamin
as the ﬁrst component of the molecular machinery to be implicated in
regulating the constitutive ﬂuid-phase endocytosis that occurs at the
blastoderm margin throughout epiboly.
Although Dynamin has a well-deﬁned role in vesicle formation
and ﬁssion in CME, studies aiming to elucidate Dynamin's role in
ﬂuid-phase endocytosis have garnered inconsistent results. Using
both drug-based (dynasore) and dominant-negative (Dnm K44A)
approaches, we show that inhibition of Dynamin can reduce ﬂuid-
phase uptake at the blastoderm margin by 62% and 52%, respec-
tively. These data are in accordance with the 60% reduction in
ﬂuid-phase uptake observed in cultured BSC-1 cells treated with
dynasore (Macia et al., 2006) and the work by Cao et al. (2007)
showing constitutive ﬂuid-phase endocytosis in epithelial cells is
reduced by 50–60% when microinjected with inhibitory Dynamin
antibodies or reduced by 70% when treated with siRNA directed
against dnm2. Thus, based on these studies in cultured cells, an
estimated 50–70% of constitutive ﬂuid-phase endocytosis occurs
in a Dynamin-dependent manner and our data support that
estimate in an in vivo context.
Notably, we found that DN-Dnm2 (K44A) was nearly as effective at
reducing ﬂuid-phase endocytosis as treatment with the small mole-
cule inhibitor dynasore. This is in stark contrast to previous studies
showing the Dnm K44A mutation to be ineffective in blocking ﬂuid-
phase endocytosis in other contexts (Altschuler et al., 1998; Damke
et al., 1994; Herskovits et al., 1993). Cao et al. (2007) showed that high
serum conditions, under which cells are typically cultured, attenuated
the effect of Dynamin inhibition on ﬂuid-phase endocytosis. The
attenuated effect is likely caused by the presence of growth factors
which are known to stimulate macropinocytic uptake of ﬂuid-phase
markers (Haigler et al., 1979; Liu et al., 2008; Racoosin and Swanson,
1989). An advantage of our system is that the embryo medium in
which we grow our zebraﬁsh embryos is serum- and growth factor-
free, thus eliminating a source of error which would underestimate
the proportion of ﬂuid-phase endocytosis that occurs in a Dynamin-
dependent manner. This feature, coupled with the abundance of
genetic and molecular tools available for use in the zebraﬁsh, makes
this system as an attractive in vivo model for future study of the
molecular mechanisms that regulate the different endocytic pathways.
Dynamin function is essential for epiboly of the zebraﬁsh blastoderm,
but Dynamin-dependent endocytosis in the YSL is dispensable
It is hypothesized that bulk endocytic removal of yolk cell
membrane ahead of the blastoderm margin during epiboly is
required to reduce the surface area of exposed yolk cell and may
help drive epiboly movements by exerting a pulling force on the
blastoderm (Betchaku and Trinkaus, 1986; Cheng et al., 2004; Kane
and Adams, 2002; Solnica-Krezel and Driever, 1994). In zebraﬁsh,
evidence suggesting yolk cell endocytosis might play a role in
driving epiboly movements came from work where destruction of
the yolk microtubule network slowed, but did not completely
arrest epiboly of the EVL (Solnica-Krezel and Driever, 1994). EVL
epiboly in this scenario was attributed to marginal endocytosis,
which occurred normally in these embryos. Our ﬁnding that
approximately 60% of endocytosis in the yolk was Dynamin-
dependent allowed us, for the ﬁrst time, to directly test whether
this phenomenon was necessary for the proper progression of
epiboly.
We found Dynamin to be required for the successful progres-
sion of epiboly, but not in the manner in which we expected.
Global inhibition of Dynamin using the inhibitor dynasore reduced
endocytosis within the yolk; however, the YSL epiboly was only
partially affected. Moreover, dynasore treatment had a more
severe impact on epiboly than DN-Dnm2 expression, yet both
means of Dynamin inhibition disrupted marginal ﬂuid-phase
uptake to a similar extent, raising the possibility that this was
not the underlying cause of the epiboly delay. Consistent with
these data, yolk-biased knockdown of Dynamin function effec-
tively reduced ﬂuid-phase endocytosis in the yolk cell, but failed to
affect epiboly progression of the blastoderm. Additionally, expres-
sion of DN-Rho restored normal epiboly in dynasore treated
embryos without restoring endocytosis at the margin. Therefore,
the Dynamin-dependent fraction of ﬂuid-phase endocytosis at the
margin is dispensable for epiboly progression.
Because Dynamin inhibition did not completely eliminate ﬂuid-
phase endocytosis in the yolk cell, we cannot deﬁnitively say that
this phenomenon plays no role in epiboly. It is possible that the
residual endocytosis in embryos with yolk-biased DN-Dnm2 or in
those rescued with DN-Rho is sufﬁcient to drive epiboly move-
ments or that other, small volume endocytic processes might
compensate for the loss of high volume endocytosis at the margin.
However, our data ﬁts with a recent model proposing that
dynamics of the actomyosin ring in the E-YSL generates all the
force necessary to drive EVL epiboly (Behrndt et al., 2012). The
model predicts that the force driving epiboly of the EVL is
generated by a combination of friction resisted actomyosin ﬂow
and circumferential actomyosin contraction within the E-YSL. The
combined force predicted to be generated by these two mechan-
isms matched with measured animal-vegetal tension within the
embryo. Thus, this model would suggest that endocytosis of yolk
membrane need not contribute any additional force for epiboly of
the EVL.
Dynamin maintains EVL cell morphology and integrity during epiboly
Inhibition of Dynamin was associated with defects in EVL cell
morphology and integrity. Treatment with dynasore caused scat-
tered cells within the EVL to adopt a rounded morphology. Live
imaging showed that this was a result of adjacent cells in the EVL
periodically losing contact at their apices and, on occasion,
rounded cells were basally extruded from the epithelium. The
barrier function of the EVL was compromised in response to
dynasore treatment, allowing the passage of ﬂuid-phase markers
into the deep cell layer. The increase in EVL permeability was
correlated with discontinuity in the distribution of the tight
junction component ZO-1 and the separation of adjacent cell
membranes at the level of the tight junction.
We propose that Dynamin-dependent maintenance of EVL
integrity is required for normal epiboly progression. When we
disrupted the EVL by dynasore treatment, DN-Dnm2 expression or
ezrin knockdown, we observed a correlating delay in epiboly.
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Furthermore, DN-Rho rescued the dynasore associated EVL defects
and also restored epiboly. These data ﬁt with a growing body of
evidence showing that the integrity and differentiation of the EVL
is essential for normal epiboly (Carreira-Barbosa et al., 2009;
Fukazawa et al., 2010; Pei et al., 2007; Sabel et al., 2009;
Siddiqui et al., 2010). While embryos treated with dynasore had
minor problems maintaining a fully differentiated EVL, the reduc-
tion in keratin gene expression was mild in comparison to poky
mutants, foxh1 morphants and embryos expressing DN-irf6 which
all have a widespread failure in EVL differentiation (Pei et al.,
2007; Sabel et al., 2009). Thus, we attribute the epiboly delay to
problems in EVL integrity rather than differentiation.
Although we saw a strong correlation between an epiboly delay
and defects in the EVL, we were not able to exclude the possibility
that defects in the deep cells also contribute to the epiboly
phenotype in dynasore treated embryos. We attempted to address
this issue by biasing expression of DN-Dnm2 in the EVL using the
krt18-kalT4A transgenic line. The limited size and distribution of
DN-Dnm2 expressing clones and late induction of DN-Dnm2
expression hindered our ability to delineate the relative contribu-
tions of the EVL and deep cells to the epiboly phenotype.
Currently, there is no method to broadly manipulate gene expres-
sion speciﬁcally in the EVL at early epiboly stages and we look
forward to the development new tools to do so.
Dynamin regulates EVL integrity by supporting ERM protein function
and antagonizing Rho activity
The most notable defect in dynasore treated embryos was the
absence of activated ERM localized to the cortex of EVL cells,
suggesting that Dynamin might be regulating EVL integrity
through promoting ERM activity and/or localization. Consistent
with this prediction, we showed that morpholino knockdown of
ezrin2 in the zebraﬁsh closely phenocopied the effects of Dynamin
inhibition. Our data are in agreement with evidence from other
systems which demonstrate that ERM protein function is crucial
for the maintenance of epithelial cell morphology and integrity
(Casaletto et al., 2011; Pilot et al., 2006; Saotome et al., 2004;
Speck et al., 2003). In these systems, the absence/reduction of ERM
function is associated with defects in actin organization, disrup-
tions in apicalbasal polarity and, in the case of the wing imaginal
disc of Drosophila moesinmutants, basal extrusion of cells from the
epithelium.
A fundamental role Dynamin plays in the regulation of EVL
integrity and epiboly appears to be to antagonize Rho activity. This
is evidenced by the successful rescue of the epiboly and EVL
phenotype of dynasore treated embryos by expression of DN-Rho.
Dynamin may be antagonizing Rho activity directly, or possibly
indirectly through the regulation of ERM. The morphological
defects observed in intestinal epithelium of mouse ezrin mutants
were associated with an increase in Rho activity (Casaletto et al.,
2011). Likewise, Moesin antagonizes Rho activity to maintain
epithelial integrity in the wing imaginal disc in Drosophila
(Speck et al., 2003). We have taken several approaches to attempt
to show that Rho activity is elevated in embryos with compro-
mised Dynamin function, but we were unable to detect any change
(data not shown). In future work, we hope to further characterize
the relationship between Dynamin, Rho and ERM in our system.
A model for Dynamin-dependent maintenance of EVL integrity during
epiboly
We present our model for Dynamin-dependent maintenance of
EVL integrity in Fig. 9. The forces which drive epiboly of the EVL
arise in the E-YSL, where a combination of friction-resisted
actomyosin ﬂow towards the animal pole and circumferential
actomyosin contraction contribute to its vegetal movement
(Behrndt et al., 2012). An essential component of this model is
that the EVL must be mechanically coupled to the actomyosin ring
within the E-YSL. This is thought to be mediated by tight junctions
(Köppen et al., 2006), which transmit the forces generated in E-YSL
to the EVL. These vegetal-ward forces pull the EVL taut, progres-
sively stretching and ﬂattening the cells, forming a squamous
surface epithelium (Kimmel et al., 1995; Sagerström et al., 2005).
Inhibition of Dynamin disrupts the generation and transmission of
tension across the epithelium, leading to abnormal and distorted
cell morphologies within the EVL and impaired epiboly. Dynasore
treatment interrupts the tight connection between the EVL and
YSL, as evidenced by irregularities in ZO-1 staining and the
occasional movement of deep cells past this connection. Further-
more, live imaging reveals that the apical connection between EVL
cells was transiently disrupted, causing individual cells to round or
stretch as they lose and regain contact with their neighbours.
The cortical cytoskeletons of neighboring cells are mechanically
coupled via the adherens junction, allowing for the transmission of
forces between cells within an epithelium (Martin et al., 2010).
Inhibition of Dynamin cause both discontinuity and mislocaliza-
tion of the adherens junction components β-Catenin and Cadherin.
We speculate that the asymmetrical localization of adherens
junction components and actin in adjacent cells may lead to
inefﬁcient coupling and, subsequently, generates defects in EVL
cell morphology. Lending support to this model, it was recently
reported that a subset of cells in the Drosophila embryo undergoes
a Myosin II-independent apical constriction, driving the formation
of the dorsal folds during gastrulation (Wang et al., 2012).
Adherens junction components shift basally in cells just prior to
their constriction, providing an asymmetry in junction localization
between neighboring cells. This asymmetry was found to be
necessary to drive cell shape changes and subsequent morphogen-
esis of the epithelium.
We propose that the defects in adherens junction continuity
and localization that arise from Dynamin inhibition are, at least in
part, caused by the deﬁciency of activated ERM at the periphery of
EVL cells. As in other epithelia where ERM proteins are absent or
mislocalized (Casaletto et al., 2011; Pilot et al., 2006), we observed
a correlating basal spread of adherens junction components in the
Fig. 9. A model for Dynamin-dependent maintenance of EVL integrity during
epiboly. (See accompanying text for details) Brieﬂy, Dynamin is required for the
generation and transmission of tension within the EVL during epiboly. The
adherens junctions, which mechanically couple cells within the EVL, are disrupted
in response to Dynamin inhibition, preventing the efﬁcient transmission of forces
across the EVL. Inhibition of Dynamin also disrupts tight junctions which attach the
EVL to each other and to the E-YSL, preventing the generation of tension within
the epithelium. The inefﬁcient generation and transmission of forces across the
epithelium leads to aberrant cell morphologies and delays in epiboly.
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EVL of embryos treated with dynasore. Notably, these tissues also
displayed defects in cell morphology and integrity, reminiscent of
those induced by Dynamin inhibition. In addition, we found that
expression of DN-Rho was capable of restoring cell morphology
and integrity of the EVL in embryos treated with dynasore.
How Dynamin regulates ERM activity/localization and antag-
onizes Rho activity remains an open question. Here, we offer two
possibilities. The ﬁrst relates to Dynamin's well-deﬁned role in
vesicle scission during endocytosis. Similar to what is observed in
the maintenance of stable adherens junctions (Georgiou et al.,
2008; Langevin et al., 2005), a Dynamin-dependent endocytic
pathway might regulate level and localization of activated ERM
at the cortex by regulating its recycling. Inhibition of Dynamin-
dependent endocytosis may lead to the accumulation of ERM, or a
factor which regulates its activity, in ectopic regions of the cell
cortex and deplete the pool of protein available to be recycled back
to the intercellular junction. If Dynamin regulates EVL integrity
through an endocytosis-based mechanism, however, it is unlikely
that the endocytic route is CME since inhibition of CME had a
relatively mild impact on EVL morphology (SEL unpublished data).
The second mechanism of Dynamin action we propose relates
to its actin organizing function. Recent work has shown that
Dynamin can directly bind and regulate the actin cytoskeleton
by promoting the uncapping of barbed ends by gelsolin. In
addition, Dynamin directly interacts with the SH3 domain-
containing Cortactin, a factor which stabilizes newly formed actin
branches and interacts with N-WASP to promote Arp2/3-depen-
dent actin nucleation (Martinez-Quiles et al., 2004; Mooren et al.,
2009; Weaver et al., 2002). Inhibition of Dynamin function may
disrupt the balance between branched and unbranched actin,
which has been shown to be important in the maintenance of
other epithelia (Georgiou et al., 2008; Hudson and Cooley, 2002;
Janody and Treisman, 2006; Jezowska et al., 2011). This balance
may be required for the maintenance of active ERM at the cell
cortex (Bachman and McClay, 1995; Woodward and Crouch, 2001)
or might be required for efﬁcient vesicle scission (Georgiou et al.,
2008; Hudson and Cooley, 2002). In this scenario, DN-Rho would
rescue the effect of Dynamin inhibiton by restoring this balance.
Moving forward, we hope to further elucidate the mechanism
through which Dynamin regulates ERM and Rho activity to
promote epithelial integrity within the EVL.
Materials and methods
Zebraﬁsh
Zebraﬁsh embryos were obtained from natural matings of
wildtype AB strain ﬁsh or transgenic krt18:KalTA4-ERT2 ﬁsh. We
generated a conditional EVL-speciﬁc Gal4 driver line, krt18:
KalTA4-ERT2, in which a fusion of the zebraﬁsh-optimized Gal4
and the tamoxifen-binding domain (ERT2) is driven by a keratin 18
promoter (MT, a manuscript submitted elsewhere). Embryos were
raised in embryo medium at 28 1C and staged according to Kimmel
et al. (1995).
Fluid-phase endocytosis and vesicle quantiﬁcation
Manually dechorionated embryos were injected with RNA
encoding membrane-bound RFP (mRFP) at 1-cell stage, bathed in
FITC for 30 min at the stage indicated, and imaged live at the
margin by confocal microscopy. For each image/embryo (n),
vesicles were manually counted from confocal Z-stacks using the
point tool in Volocity (Perkin Elmer). From each image,
the number of FITC-containing vesicles localized to YSL versus
the maginal EVL (ﬁrst 3 tiers of cells) was counted. The number of
vesicles localized to the EVL or YSL was expressed as a percentage
of the total number of vesicles counted in an image/embryo and
these values were averaged to generate the mean percentage of
total vesicles residing in the EVL versus YSL. Inhibitor treated
embryos and those expressing DN-Dyn2 or DN-Rho were placed in
FITC at approximately 40% epiboly and imaged between 40 and
50% epiboly. The total number of marginal, FITC-containing vesi-
cles was quantiﬁed from maximum projections of Z-stack images.
The data were analysed with two-way ANOVAs with treatment
and day as the independent factors using JMP version 9. To meet
the assumptions of ANOVA, raw vesicle counts were transformed
by taking the square-root. The treatmentnday interactions were
not signiﬁcant so they were not included in ﬁnal analyses. The
least squares means (mean vesicle numbers adjusted for the effect
of day) were plotted.
Inhibitor treatments
Dechorionated embryos were bathed in embryo medium alone,
embryo medium containing 0.1% DMSO or embryo medium
containing 75 μM Dynasore. Dynasore (Sigma) was dissolved in
DMSO and subsequently diluted such that the ﬁnal working
solution contained 0.1% DMSO. Unless otherwise speciﬁed,
embryos were bathed in their respective treatments starting at
oblong-sphere stage (3.75 hpf) until they were imaged or ﬁxed at
the stage indicated.
DNA constructs, RNA and morpholinos
To generate rat dn-dnm2 RNA, pcDNA3.1(-)HA-Dnm2 K44A
(ATCC, MBA-95) was linearized with HindIII and mRNA was
in vitro transcribed from T7. Human dn-rho RNA was transcribed
from pCS2þ-Rho A-N19 linearized with XhoI, using T3 polymer-
ase. mRNA encoding membrane-bound RFP (mRFP), membrane-
bound GFP (mGFP) or nuclear localized mCherry (H2A mCherry)
were transcribed from SP6, using pCS2þ-mrfp, -mgfp or
-H2Amcherry linearized by NotI as template. All mRNAs were
in vitro transcribed using the T7/T3/SP6 mMESSAGE mMACHINE
kit (Ambion) and were puriﬁed using the Ambion MEGAclear kit.
The ezrin2 MO (GeneTools) was as described in Link et al. (2006)
and Schepis et al. (2012).
Microinjection
For global expression of DN-Dnm2, DN-Rho, mRFP and/or H2A
mCherry, mRNA was microinjected into the yolk cell of embryos at
the 1-cell stage as previously described (Bruce et al., 2003). Yolk-
biased expression of DN-Dnm2 was achieved by microinjecting
mRNA into the yolk cell at 16- to 32-cell stage. Estimated doses of
injected mRNA/MO are as follows: dn-dnm2 (340 pg), dn-rho
(260 pg), ezrinMO (8 ng).
Mosaic expression in the EVL
The full-length coding sequence of zebraﬁsh dnm2-like-k44a
(dn-dnm2l) (gift from T. Ogura) was blunt end cloned into the
EcoRV site of pBR-Tol2-UAS-double-GFP-CAAX, a modiﬁed version
of the bi-directional UAS system (Distel et al., 2010). Empty vector
(cntl inj) or vector containing dn-dnm2l was injected directly into
the blastoderm of embryos obtained from transgenic krt18:
KalTA4-ERT2 ﬁsh at the 1-cell stage, along with tol2 RNA. Embryos
were bathed in 0.5 mM Z-4-hydroxytamoxifen (Sigma H7904: a
stock of 5 mM in ethanol) starting at 30% epiboly.
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Time-lapse imaging
Embryos were injected at the 1-cell stage with RNA encoding
mGFP and treated with dynasore as described above. At dome
stage, embryos were mounted in coverslip bottomed dishes
(MatTek) in 0.4% low melt agarose containing 75 μm dynasore.
Confocal Z-stack images were taken from the animal pole, at 4 min
intervals. Still XY frames were taken from a single plane in the
sub-apical region. Stacks were rotated into the XZ plane to
visualize basal extrusion. Analysis of time-lapse movies was
conducted using Volocity software.
Whole-mount immunostaining and in situ hybridization
Dechorionated embryos at the indicated stages were ﬁxed in 4%
paraformaldehyde or formaldehyde overnight at 4 1C. Embryos
were washed in 0.1% Triton-X in PBS (PBT), permeablized in 0.8%
PBT for 1 h at room temperature, then blocked at room tempera-
ture for 2–5 h in 5–10% normal goat serum/1% DMSO/0.5–5%
Triton-X/PBS. Embryos were incubated in primary antibodies
and/or phalloidin diluted in block solution overnight at 4 1C and
secondary antibodies at room temperature for 3 h, then mounted
in ProLong Gold Antifade (Invitrogen) or Antifade with DAPI for
imaging. Dilutions were as follows: Phalloidin Alexa488 (Invitro-
gen, 1:200), anti-aPKC (Santa Cruz, 1:200), anti-β-Catenin (Sigma,
1:200), anti-pan-Cadherin (Abcam, 1:1000), anti-cleaved Caspase
3 (Cell Signaling, 1:100), anti-P-ERM (Cell Signaling, 1:25), anti-ZO-
1 (Invitrogen, 1:200). Secondary antibodies used were as follows:
goat-anti-mouse Alexa488 (Invitrogen, 1:500) and goat-anti-rabbit
Cy3 (Jackson ImmunoResearch, 1:500). Sytox staining was per-
formed by diluting sytox green (Invitrogen) to a ﬁnal concentra-
tion of 0.5 μM to the ﬁxative. Whole-mount in situ hybridization
for keratin 4 was carried out as described by Jowett and Lettice
(1994). Probe was generated by linearizing pBS(þ)-keratin 4 with
Not I and in vitro transcribing from T7.
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